HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toxicity of dipivalyl epinephrine.

Abstract
Fourteen patients with open-angle glaucoma applied one drop 0.1% dipivalyl epinephrine topically twice daily for three years. Four of the 14 patients developed severe blepharoconjunctivitis after 17 to 26 months of exposure to this epinephrine prodrug. Two of the four patients with dipivalyl epinephrine intolerance had a history of epinephrine intolerance. Three other patients had asymptomatic conjunctival hyperemia after 30 months of dipivalyl epinephrine exposure. No patients had conjunctival pigment deposits or cardiovascular side effects. The exfoliative cytology of two patients was characterized by karyomegaly of the conjunctival epithelial cells.
AuthorsT Wandel, M Spinak
JournalOphthalmology (Ophthalmology) Vol. 88 Issue 3 Pg. 259-60 (Mar 1981) ISSN: 0161-6420 [Print] United States
PMID7231914 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Ophthalmic Solutions
  • Pilocarpine
  • dipivefrin
  • Epinephrine
Topics
  • Aged
  • Blepharitis (chemically induced)
  • Conjunctivitis (chemically induced)
  • Epinephrine (adverse effects, analogs & derivatives)
  • Female
  • Follow-Up Studies
  • Glaucoma (drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Ophthalmic Solutions
  • Pilocarpine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: